Skip to main content

Diabetes Mellitus: Pathophysiology

 PATHOPHYSIOLOGY OF DM

IMPAIRED INSULIN SECRETION

  • A pancreas with normal Beta cell function is able to adjust insulin production to maintain normal blood glucose levels.
  • Hyperinsulinemia or high blood levels of insulin is an early finding of T2 DM.
  • More insulin is secreted to maintain normal blood glucose levels until eventually the pancreas can no longer produce sufficient insulin.
  • Impaired Beta cell function results in reduced ability to produce a first-phase insulin response sufficient to signal the liver to stop producing glucose after a meal.
  • As DM progresses, large numbers of patients with T2DM eventually loses all beta cell function and require exogenous insulin to maintain the blood glucose levels. 


INSULIN RESISTANCE

  • Insulin resistance is the primary factor that differentiates T2DM from other forms of diabetes.
  • Insulin resistance maybe present for several years prior to the diagnosis of DM.
  • Insulin resistance occurs more significantly in skeletal muscles and liver.
  • Insulin resistance in the liver poses a double threat because the liver becomes nonresponsive to insulin for glucose uptake and hepatic production of glucose after a meal does not cease which leads to elevated fasting and post-meal glucose levels.


IMAPIRED GLUCAGON SECRETION

  • Glucagon is the counter regulatory hormones produced by the beta cells that raises blood glucose levels.
  • The release of insulin and the inhibition of glucagon is glucose stimulated.
  • Most patients with a 10–20-year history of T1DM have lost their ability to release glucagon, which increases their risk of hypoglycemic unawareness.



GLUCAGON LIKE PEPTIDE AND GIP IMAPIRED 

People with T2DM have impaired phase 2 insulin release, and some have impaired glucagon-like peptide (GLP-Q) and glucose-dependent insulinotropic polypeptide (GIP) release, which further reduces the release of insulin.

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Diabetes Mellitus: Pharmacotherapy- Gliptins and a-Glycoside Inhibitors!

  PHARMACOTHERAPY:  Medications classifications include:  Sulfonyl Urea's Nonsylfonylurea Secretagogues (a-Glinides) Biguanides Thiazolidinediones a-Glucosidase Inhibitors Dipeptidyl Peptidase-4 Inhibitors (Gliptins) Sodium-glucose co-transporter (SGLT) Inhibitors  Central-Acting Dopamine Agonists Bile Acid Sequestrants Insulin therapy 5. a-GLUCOSIDASE INHIBITORS Acarbose and Miglitol are a-glucosidase inhibitors currently approved in the United States. Mechanism of Action: An enzyme that is along the brush border of the intestine cells called a-glucosidase; breaks down the complex carbohydrates into simple sugars, resulting in absorption. The a-glucosidase inhibitors work by delaying the absorption of carbohydrates from the intestinal tract, which reduces the rise in postprandial glucose levels. Therapy: As a monotherapy , a-glucosidase inhibitors primarily reduce post-prandial glucose excursions.  Clinical Use: FPG concentrations have been decreased by 40-5...
Post a Comment
Read more

Diabetes Mellitus: Types!

TYPES OF DIABETES MELLITUS 1. TYPE1 DM Type 1 DM is usually diagnosed before age 30 years, but it can develop at any age. T1DM is an autoimmune disease in which insulin producing B-cells are destroyed. The presence of Human Leucocyte Antigens (HLAs ) is associated with the development of T1DM. In addition, these individuals often develop Islet cell antibodies , Insulin Autoantibodies or Glutamic Acid decarboxylase autoantibodies . At the time of development of diagnosis of T1DM, it is usually believed that most of the patients have 80-90%loss of beta cells. The remaining beta cells function at the diagnosis creates a " HONEYMOON PERIOD" during which the blood glucose levels are easier to control, and smaller amounts of insulin are required. after this, the remaining beta cells function is completely lost, and the patients become completely deficient of insulin and hence require exogenous insulin.  2. TYPE1.5 DM:  Also referred as Latent autoimmune diabetes in Adults (LAD) ...
Post a Comment
Read more

Diabetes Mellitus: Etiology and Epidemiology!

 DIABETES MELLITIS Definition: Diabetes Mellitus (DM) describes a group pf chronic metabolic  disorders characterized by hyperglycemia that may result in long-term microvascular, macrovascular and neuropathic complications. these complications contribute to diabetes being the leading cause of: a) new cases of blindness among adults b) end stage renal diseases c)non-traumatic lower limb amputations Etiology: The increasing prevalence is caused by three influences: 1. ethnicity        2. Lifestyle       3. Age Types: a) Type 1 DM b) Type 2 DM c) Type 1.5DM d) Gestational Diabetes Mellitus (GDM) ** In type 1 DM; the body fails to make insulin. In type 2 DM; body either develops resistance to insulin or not enough insulin is produced to lower the Blood glucose levels** Epidemiology The worldwide prevalence of DM has risen over past two decades with an estimation of 30 million cases in 1985 to 177 million cases in 2000. Based on current trend...
Post a Comment
Read more